TEAM HALLAHAN LLC for ALKERMES, INC.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
"FY 23 Appropriations HR 8294, S. 4670; LHHS HR 8295; S. 4659; CJS HR 8256, S 4664 (LHHS, Interior, and Milcon VA) and HR 4505, Commerce Justice State Appropriations regarding Residential Substance Abuse Treatment program, Mentally Ill Offender Act funding, Comprehensive Opioid Recovery Centers, Center for Substance Abuse Treatment, federal programs related to opioid and alcohol use disorders and treatment; Medicaid Part D provisions, Lower Drug Costs Now Act, Prescription Drug Pricing Reduction Act; crisis stabilization and community reentry grants. FY 23 Transportation, Housing and Urban DevelopmentAppropriations related to housing pilot for homeless individuals with severe mental illness. FY2023 Consolidated Appropriations Act (HR 2617).
Foreign entity interest: Alkermes PLC is a Foreign Parent with tangential interests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATE HALLAHAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.